SECTION 450:70-6-8. Long term managed withdrawal

(a)   There shall be written policy stating a patient may be admitted to long-term managed withdrawal regardless of age. Patients under the age of eighteen (18) with written parent or guardian approval.

(b)   Methadone is required to be administered daily in reducing doses to reach a drug-free state over a period not to exceed one hundred and eighty (180) days. Buprenorphine shall be administered as determined by the OTP medical director.

(c)   The patient is required to be under observation while ingesting the drug at least six (6) days a week. This is not required for buprenorphine.

(d)   Initial and random monthly drug screening tests must be performed on each patient.

(e)   Initial service plans and monthly service plan reviews are required.

(f)   All other requirements of comprehensive maintenance treatment apply.

(g)   A history of one year of opioid dependence and an attempt at another form of treatment is not required for admission to long-term withdrawal management.

(h)   Compliance with 450:70-6-8 may be determined by:

(1)   A review of policies and procedures,

(2)   Treatment records,

(3)   Interviews with staff, and

(4)   Other facility documentation.

[Source: Added at 24 Ok Reg 2634, eff 7-12-07; Amended at 26 Ok Reg 1303, eff 7-1-09; Amended at 30 Ok Reg 1425, eff 7-1-13; Amended at 34 Ok Reg 1830, eff 10-1-17]